Login

Ekso Bionics Holdings, Inc EKSO CEO Jack Peurach on 2019 Results 00:00:00

Share On Facebook Share On Twitter

Ekso Bionics Holdings, Inc EKSO CEO Jack Peurach on 2019 Results

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:00:00
Stefan Weber, CEO, Newron Pharmaceuticals
00:10:00
Arlo Technologies' Stock Surges on Debut: Did They Underprice Their IPO? | Matthew McRae, CEO, Arlo Technologies Inc.
00:10:00
Royal Road Minerals' Exploration Initiatives and Strategic Partnerships in Latin America
00:10:00
Chairman John Taylor Predicts Potential U.S. Recession and Analyzes European Central Bank and Federal Reserve Policies in Bloomberg Originals Interview
00:10:00
VD Clein Ullenvik and CFO Irene Wisenborn Belander Present the Company | Clein Johansson Ullenvik - President and CEO of Alligo AB
00:10:00
Empowering Europe's Future: Mina do Barroso Lithium Project
00:10:00
Tamago CEO Highlights Strategic Advancements and Undervalued Potential of Polymetallic Project in Northern Quebec
00:10:00
Importance of Historical Knowledge in Policy Formulation
00:10:00
Building a Hydrogen Future: Insights from Global Partners at the Northeast Hydrogen Infrastructure Summit | Ken Piddington - CIO, Global Partners LP
00:10:00
American Pacific Mining Project: Boron Extraction and Expansion
00:10:00
Or Yissachar on IDF Insights and Challenges Facing Israel|Or Yissachar, Professor, Paris School of International Affairs
00:00:00
Tal Yalon, M.D., Mayo Clinic

© 2026 Nehu